3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
46
Lymphoma, Mantle-Cell
20
Lymphoma, Follicular
13
Waldenstrom Macroglobulinemia
12
Lymphoma, Non-Hodgkin
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma
11
Lymphoma, B-Cell
10
Leukemia
9
Recurrence
8
Multiple Myeloma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphoid
4
Leukemia, B-Cell
4
Hodgkin Disease
4
Bronchiolitis Obliterans Syndrome
4
Hematologic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Lung Neoplasms
2
Leukemia, Prolymphocytic
2
Leukemia, Myeloid, Acute
2
Graft vs Host Disease
2
Chromosome 17 deletion
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Interventions
Cyclophosphamide
33
fludarabine phosphate
31
Peripheral Blood Stem Cell Transplantation
28
Whole-Body Irradiation
27
Rituximab
24
Mycophenolic Acid
24
Busulfan
22
Cyclosporine
19
Tacrolimus
17
Etoposide
17
Antilymphocyte Serum
17
Filgrastim
14
Methotrexate
12
Melphalan
12
Radiotherapy
10
Granulocyte Colony-Stimulating Factor
8
Cord Blood Stem Cell Transplantation
8
thymoglobulin
6
Sirolimus
6
Carmustine
6
Flow Cytometry
5
Cytarabine
5
ibritumomab tiuxetan
4
Vincristine
4
Prednisone
4
Polymerase Chain Reaction
4
Methylprednisolone
4
Gene Expression Profiling
4
Dexamethasone
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large-Cell, Immunoblastic
×
ibrutinib
×
Clear all
No trials found.